Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BRD4 | O60885 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.34 |
| ▸ | HCRTR2 | O43614 | 1/20 | 0.33 |
| ▸ | CES2 | O00748 | 2/20 | 0.33 |
| ▸ | CES1 | P23141 | 2/20 | 0.33 |
| ▸ | F10 | P00742 | 2/20 | 0.33 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | OPRM1 | P35372 | 3/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | OPRD1 | P41143 | 2/20 | 0.31 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.31 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.31 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.31 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.31 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | ATM | Q13315 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2700331 | 1.00 | BRD4 (0.35) | BRD4L3MBTL1PRMT1HCRTR2CES2 | |
| SCHEMBL1468125 | 1.00 | BRD4 (0.35) | BRD4L3MBTL1PRMT1HCRTR2CES2 | |
| SCHEMBL2289941 | 0.81 | — | — | |
| SCHEMBL18082673 | 0.80 | KDM4E (0.40) | BRD4L3MBTL1PRMT1CES2CES1 | |
| SCHEMBL2700864 | 0.80 | FFAR3 (0.33) | SMN1; SMN2MAPT | |
| SCHEMBL663885 | 0.80 | BRD4 (0.38) | BRD4PRMT1CES2CES1F10 | |
| SCHEMBL1908605 | 0.80 | KDM4E (0.40) | BRD4L3MBTL1PRMT1CES2CES1 | |
| SCHEMBL12549788 | 0.80 | BRD4 (0.38) | BRD4PRMT1CES2CES1F10 | |
| SCHEMBL1468235 | 0.80 | FFAR3 (0.33) | SMN1; SMN2MAPT | |
| SCHEMBL2701515 | 0.80 | FFAR3 (0.33) | SMN1; SMN2MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2450333-B1 | METHOD FOR PRODUCING ALICYCLIC ALCOHOL | MITSUBISHI GAS CHEMICAL CO (JP) | 2017-07-26 | — | — | EP | disclosed |
| US-8816136-B2 | Method for producing alicyclic alcohol | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2014-08-26 | — | — | US | disclosed |
| US-8816136-B2 | Method for producing alicyclic alcohol | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2014-08-26 | — | — | US | disclosed |
| US-8816136-B2 | Method for producing alicyclic alcohol | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2014-08-26 | — | — | US | disclosed |
| US-20120238784-A1 | METHOD FOR PRODUCING ALICYCLIC ALCOHOL | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2012-09-20 | — | — | US | disclosed |
| US-20120238784-A1 | METHOD FOR PRODUCING ALICYCLIC ALCOHOL | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2012-09-20 | — | — | US | disclosed |
| EP-2450333-A1 | METHOD FOR PRODUCING ALICYCLIC ALCOHOL | Mitsubishi Gas Chemical Company, Inc. (JP) | 2012-05-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120238784-A1 | METHOD FOR PRODUCING ALICYCLIC ALCOHOL | ADH1C, ADH1A, ADH5 | BRD4 893/4885L3MBTL1 1549/4885PRMT1 1921/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.